Viewing Study NCT06409624


Ignite Creation Date: 2025-12-18 @ 8:11 AM
Ignite Modification Date: 2025-12-18 @ 8:11 AM
Study NCT ID: NCT06409624
Status: None
Last Update Posted: 2025-10-06 00:00:00
First Post: 2024-05-07 00:00:00
Is Possible Gene Therapy: False
Has Adverse Events: False

Brief Title: Association Between Biomarkers and Kidney Function Decline in Pulmonary Hypertension
Sponsor: None
Organization:

Study Overview

Official Title: Association Between Biomarkers and Kidney Function Decline in Patients With Pulmonary Hypertension
Status: None
Status Verified Date: 2025-09
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: PH is a severe, progressive disease associated with right ventricular dysfunction, right-sided heart failure (HF) and death. Kidney disease is present in approximately 35% of patients with PH, and its presence is associated with an enhanced risk for adverse outcomes, with the risk increasing incrementally with declining kidney function. Poor right ventricular function may increase venous congestion, alter ventricular interdependence, decrease effective cardiac output and activate the renin-angiotensin- aldosterone system, thereby aggravating kidney disease.

There is a crucial need to better understand the pathophysiological mechanisms linking the failing right heart and the kidney. To date, diagnostic and prognostic biomarkers of kidney disease in PH are lacking. The objective of this study is to examine the association between urinary and plasma biomarkers and change in eGFR among patients with PH.
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: